Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study-Reference-Cited by-同舟云学术

Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study

Published:2019-08-20 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Li Xiaoyang,Dong Yuexin,Li Ya,Ren Ruibao,Wu Wen,Zhu Hongming,Zhang Yunxiang,Hu Jiong,Li Junmin^ORCID

Funder

National Natural Science Foundation of the People’s Republic of China

Clinical Research Plan of SHDC

Shanghai Collaborative Innovation Program on Regenerative Medicine and Stem Cell Research

Clinical Research Center, Shanghai Jiao Tong University School of Medicine

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-5975-8.pdf

Reference39 articles.

1. Juliusson G, Lazarevic V, Horstedt A, et al. Acute myeloid leukemia in the real world: why population-based registries are needed. Blood. 2012;119(17):3890–9.

2. Thein MS, Ershler WB, Jemal A, et al. Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over three decades. Cancer. 2013;119(15):2720–7.

3. Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. Blood. 2006;107(9):3481–5.

4. Rao AV, Valk PJ, Metzeler KH, et al. Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia. J Clin Oncol. 2009;27(33):5580–6.

5. Kantarjian H, Ravandi F, O'Brien S, et al. Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia. Blood. 2010;116(22):4422–9.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group;Heliyon;2023-04

2. Characterization of the Newly Established Homoharringtonine- (HHT-) Resistant Cell Lines and Mechanisms of Resistance;Journal of Oncology;2022-08-30

3. Low-Dose 5-Aza and DZnep Alleviate Acute Graft-Versus-Host Disease With Less Side Effects Through Altering T-Cell Differentiation;Frontiers in Immunology;2022-02-24

4. Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing;British Journal of Cancer;2021-10-22

5. The potential of cord blood to replenish young immune cells against cancer;Aging and Cancer;2021-06